US becomes first country in the world to approve gamechanger Alzheimer’s drug lecanemab
US health officials today approved the first Alzheimer’s drug proven to slow the condition – in what could be a breakthrough for millions of patients. Lecanemab, which will be sold under the brand name Leqembi, instantly becomes the most effective treatment on the market after being given accelerated approval by the Food and Drug Administration (FDA)…